- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02511548
Increasing Medical Male Circumcision Uptake
Increasing Medical Male Circumcision Uptake in Orange Farm (South Africa): An Operational Study of Demand Creation
Study Overview
Status
Intervention / Treatment
Detailed Description
The World Health Organization and the United Nations Programme on HIV/AIDS recommend voluntary adult medical male circumcision as an intervention against HIV in Africa since 2007 and has estimated that achieving 80% male circumcision coverage would have a major public health impact. Despite evidence of its effectiveness, feasibility, cost-effectiveness and acceptability, its roll-out in Eastern and Southern Africa, the region where HIV prevalence is highest in the world, remains slow. Developing and testing innovative strategies to accelerate voluntary adult medical male circumcision roll-out is thus necessary. As a target community of this prevention method, Orange Farm (Gauteng Province) is a prime setting to conduct operational research. The team presenting this project conducted the first voluntary adult medical male circumcision randomized trial (ANRS-1265), successfully led the ANRS-12126 voluntary adult medical male circumcision roll-out, and has just completed the ANRS-12285 study on voluntary adult medical male circumcision and HIV incidence. Due to the roll-out, male circumcision prevalence increased from 12% in 2008 to 53% in 2011 in the township, but to date this prevalence has remained stagnant.
The main objective of this study is to reach 80% circumcised men in randomized clusters of Orange Farm (Gauteng Province), a township where voluntary adult medical male circumcision roll-out is ongoing since 2007.
Existing communication strategies will be revised and supplemented by personalised individual discussions to increase motivation for voluntary adult medical male circumcision and translate it into actual uptake.
The project consists of: 1) A preparatory phase to establish collaborations and prepare the communication activities, 2) a survey phase during which a) a mass communication campaign will be launched and b) 300 uncircumcised men selected from randomized clusters of Orange Farm will be recruited and undergo a baseline assessment including voluntary adult medical male circumcision general counselling, and 3) a follow-up phase during which repeated motivational interviews will be conducted to address their individual reasons for not being circumcised. Financial incentive will also be tested in a randomized trial.
Willing men will be referred to the free local voluntary adult medical male circumcision clinic and asked to attend an interview on the reasons that motivated them to become circumcised. At the end of the study, male circumcision prevalence among participants will be calculated. Factors associated with voluntary adult medical male circumcision uptake will be studied.
The survey phase will include a total of 600 uncircumcised and circumcised adult men. Among them, an expected 200 uncircumcised men will be included in the follow-up phase.
Participants will receive a financial compensation for their participation.
The study will last about 4 months.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Uncircumcised men
- Willing to participate
- Living in Orange Farm
- Able to speak and read English, Sotho or Zulu
Exclusion Criteria:
- Unable to give informed consent
- Planning to leave the study area within the next year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Financial incentive
|
Financial incentive will be proposed to participant of the intervention arm
|
|
No Intervention: Control
No financial incentive
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Male circumcision uptake
Time Frame: 3 weeks
|
The proportion of participants who will accept to become circumcised during the course of the study in each arm.
|
3 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bertran Auvert, MD, PhD, University of Versailles
Publications and helpful links
General Publications
- Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10(9):e1001509. doi: 10.1371/journal.pmed.1001509. Epub 2013 Sep 3.
- Thirumurthy H, Masters SH, Rao S, Bronson MA, Lanham M, Omanga E, Evens E, Agot K. Effect of providing conditional economic compensation on uptake of voluntary medical male circumcision in Kenya: a randomized clinical trial. JAMA. 2014 Aug 20;312(7):703-11. doi: 10.1001/jama.2014.9087.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MCUptake
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circumcision, Male
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Medical University of South CarolinaCompleted
-
Simunye Primary Health CareCompleted
-
Kocatepe UniversityCompleted
-
FHI 360Weill Medical College of Cornell University; Bill and Melinda Gates Foundation and other collaboratorsCompletedMale CircumcisionKenya, Zambia
-
ProgressusUnknownMale | CircumcisionZambia
-
Tehsil Headquarter HospitalCompleted
Clinical Trials on Financial incentive
-
Imperial College LondonNational Health Service, United KingdomCompletedDiabetes | Diabetic Retinopathy
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceUnknown
-
University of California, San DiegoUnited States Department of Agriculture (USDA); Latino Health Access; California... and other collaboratorsActive, not recruiting
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Harvard Pilgrim Health CareSeattle Children's HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceNot yet recruitingObesity | Obesity RecidivismFrance
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
State University of New York at BuffaloActive, not recruitingDiabetes Mellitus, Type 2United States
-
University of Alabama at BirminghamCenters for Disease Control and PreventionCompletedGlaucoma | Diabetic Retinopathy | Refractive Errors | Cataract | Behavior, HealthUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States